Kunming Longjin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- The start date for the Company's stock entering the delisting transition period is June 6, 2025, lasting for fifteen trading days, with the expected last trading date being June 26, 2025. The Company's stock will be delisted on the next trading day after the transition period ends.
- During the delisting transition period, the Company will not plan or implement major asset restructuring matters.
- Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect transactions in a timely manner before the stock is delisted.
- For judicial freeze matters expiring during the initial registration period of the delisted companies section, which will occur after the stock is delisted, it is recommended that the competent authorities handle the renewal procedures in advance through the original execution assistance channels before the stock is delisted.